Gradientech presents QuickMIC® at ECCMID 2022
Uppsala, Sweden, April 22, 2022. Gradientech will display its ultra-rapid and precise diagnostic system QuickMIC® on April 23-26 at ECCMID in Lisbon, one of the world's leading conferences in clinical microbiology and infectious diseases with more than 14,000 participants.
“We are very pleased to finally showcase our QuickMIC system for leading experts in the field. QuickMIC has the potential to revolutionize the market for antibiotic susceptibility testing since it delivers results ultra-rapidly which is of great importance for the critically ill patient and the treating physician in addition”, says Sara Thorslund, CEO of Gradientech.
QuickMIC is the potentially fastest system for growth-based testing of antibiotic resistance in sepsis patients. Clinical studies are currently underway to enable the launch of the QuickMIC system for diagnostic use first in Europe, then in the USA.
Discover QuickMIC at ECCMID 2022
- April 23-26
- Feira Internacional de Lisboa (FIL)
- Booth 2-6.1, Exhibition hall 3
QuickMIC studies presented
P0867, Malmberg C et. al, Rapid detection of carbapenem and third-generation cephalosporin resistance directly from positive blood cultures.
P0765, Andersson H.E et al, Clinical evaluation of the QuickMIC AST system for ultra-rapid MIC determination using positive blood cultures from patients with bacteraemia.
For more information please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80
Next-generation antimicrobial susceptibility testingTake a look at our E-book